State of Wisconsin Investment Board
TRVI icon

State of Wisconsin Investment Board’s Trevi Therapeutics TRVI Stock Holding History

State of Wisconsin Investment Board’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
82,753
-51,978
-39% -$756K ﹤0.01% 1608
2026
Q1 		$1.61M Buy
134,731
+14,165
+12% +$159K ﹤0.01% 1491
2025
Q4 		$1.51M Sell
120,566
-2,710
-2% -$31.3K ﹤0.01% 1514
2025
Q3 		$1.13M Buy
123,276
+6,031
+5% +$45.2K ﹤0.01% 1569
2025
Q2 		$641K Sell
117,245
-57,900
-33% -$360K ﹤0.01% 1749
2025
Q1 		$1.1M Buy
175,145
+110,645
+172% +$528K ﹤0.01% 1459
2024
Q4 		$266K Buy
+64,500
New +$206K ﹤0.01% 2052

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

State of Wisconsin Investment Board's TRVI Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Trevi Therapeutics (TRVI) stake by 39% in Q2 2026, selling an estimated $756K and leaving 82,753 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1608.

State of Wisconsin Investment Board first reported a position in TRVI in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.61M in Q1 2026. 217 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • State of Wisconsin Investment Board held 82,753 shares of Trevi Therapeutics worth $1.54M as of Q2 2026.
  • State of Wisconsin Investment Board sold 51,978 Trevi Therapeutics shares in Q2 2026, an estimated $756K.
  • Trevi Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1608 holding.
  • State of Wisconsin Investment Board first reported a position in Trevi Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • State of Wisconsin Investment Board's Trevi Therapeutics position peaked at $1.61M in Q1 2026.
  • 217 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.